#USA #New York #The Gross Law Firm #Baxter International #class action notice

Baxter International Inc. Class Action Notice

In a recent announcement, The Gross Law Firm has urged shareholders of Baxter International, Inc. (NYSE: BAX) to reach out before December 15, 2025, to understand their rights and potential claims. This call to action arises amid serious allegations regarding the company’s product, the Novum LVP, which is reported to have systemic defects that could pose serious risks to patients.

Background of Baxter International, Inc.

Baxter International is a well-known player in the healthcare space, providing a range of medical products and technologies. However, concerns have started to surface regarding the safety and efficacy of one of its recently launched products—the Novum LVP. Allegations state that this device has suffered significant malfunctions, leading to grave consequences for users, including incidents of underinfusion and overinfusion of fluids, and in some cases, complete failure to deliver necessary fluids. These issues have reportedly resulted in severe injury and potential fatalities among patients relying on this product.

Allegations Detailed

During the designated class action period from February 23, 2022 to October 29, 2025, it is alleged that Baxter failed to disclose crucial information to investors. Key problems identified include:

• - Device Malfunctions: Multiple reports of malfunctions, serious injuries, and death linked to the Novum LVP have not been adequately addressed.
• - Inadequate Remedial Measures: Baxter's response through customer alerts reportedly fell short, as the underlying design flaws continued to pose serious risks.
• - False Representations: Investors claim that Baxter’s assurances concerning the safety and efficacy of the Novum LVP were misleading, inflating the stock prices based on unfounded statements about the product’s performance and customer satisfaction.

Given these events, shareholders who acquired BAX stocks during the specified period are strongly encouraged to register their claims before the looming deadline of December 15, 2025. Such a registration is essential for those wishing to be considered as lead plaintiffs, although it is not necessary for participating in the case.

Next Steps for Investors

Upon registering, shareholders will gain access to a portfolio monitoring system that will provide ongoing updates regarding the class action's progress. This allows investors to stay informed and reassured throughout the litigation process. The Gross Law Firm emphasizes that involvement in this case carries no financial risks or obligations for those participating.

Why Choose The Gross Law Firm?

The Gross Law Firm is recognized nationally for its dedication to protecting investor rights. With a focus on cases involving corporate deceit and fraud, it strives to ensure that entities act responsibly and transparently in their business practices. Their commitment to supporting investors in recovering losses due to misleading corporate behavior is paramount.

Contact Information

For those interested in pursuing this matter, The Gross Law Firm can be contacted at:

• - Address: 15 West 38th Street, 12th floor, New York, NY, 10018
• - Email: [email protected]
• - Phone: (646) 453-8903

Visitors can also find detailed submission forms and more information on their website.

Remember, swift action is critical to protect your rights as an investor in Baxter International. Don’t wait until the deadline passes—take action today.